PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

NCT02226965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Diffuse Large B-Cell

Interventions

DRUG: PNT2258

Sponsor

Sierra Oncology LLC - a GSK company